CME Activities

Webcast Details

Return to Search

Anticoagulant and Antiplatelet Update

All webcasts are free to view. You must only pay if you wish to access the post test following the webcast, in order to earn CME credit. You must be logged in to take the Post-Test.

Dates
12/04/2020 - 12/04/2023
Authors
Danielle Blais, RPh, and Tiffany Ortman, RPh
Speakers
Dr. Danielle Blais      Dr. Tiffany Ortman
Location
Online
Objective(s)
As a result of this educational activity, webcast participants will be able to:  DETERMINE optimal oral anticoagulant based on patient-specific characteristics; RECOMMEND monitoring for direct oral anticoagulants; DESCRIBE the role of aspirin and oral P2Y12 inhibitors for patients with stable ischemic heart disease or acute coronary syndromes with or without percutaneous coronary intervention; and EVALUATE the advantages and disadvantages of the different P2Y12 inhibitors.
Description

Today on MedNet21, we're going to discuss Anticoagulant and Antiplatelet Update.

Anticoagulant

This presentation will review the anticoagulants available for use in atrial fibrillation and for the outpatient treatment of venous thromboembolism. Focus will be on the direct oral anticoagulants.

Antiplatelet

This presentation will review the antiplatelet recommendations for stable ischemic heart disease and acute coronary syndrome patients who may or may not have a percutaneous coronary intervention. The differences in the oral P2Y12 inhibitors, clopidogrel, prasugrel, and ticagrelor, will be covered.

Price(s)
Type Price
Standard Price $25.00
OSU Affiliated Faculty/Staff $0.00
MedNet 21 Hospital Subscribers $0.00
Accreditation Statement

The Ohio State University Center for Continuing Medical Education (CCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University Center for Continuing Medical Education (CCME) designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit is only awarded after successful completion of post-test.
ABIM MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Technical Support
Click Here for technical support documentation.
Downloadable Files
to view PDFs download Adobe Reader
Name
Anticoagulant and Antiplatelet Update - 2
Anticoagulant and Antiplatelet Update - 4
Anticoagulant and Antiplatelet Update - 2 color
Disclosure Information for Planning Committee Members and Speakers
Listen to Audio Only CME Podcasts
http://u.osu.edu/mednet21/2014/12/01/listen-to-audio-only-cme-podcasts/
Recommended Reading: Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670541/
Recommended Reading: From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary Syndromes: JACC State-of-the-Art Review
https://pubmed.ncbi.nlm.nih.gov/31537272/
You must be logged in to take the Pre-Test
You must be logged in to take the Post-Test.
My CCME Account
CCME Username
Your username is an email address
Password
Forgot Your Password?